Ponni Symbiologicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 107.39%
(FY 2022)
- Profit -158.99%
(FY 2022)
- Ebitda 63.48%
(FY 2022)
- Net Worth -235.59%
(FY 2022)
- Total Assets -6.23%
(FY 2022)
About Ponni Symbiologicals
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Praveen Marimuthu, Preethi Marimuthu, and Kokila Marimuthu serve as directors at the Company.
- CIN/LLPIN
U01100TZ2019PTC031581
- Company No.
031581
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 2019
- Date of AGM
20 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ponni Symbiologicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Preethi Marimuthu  | Managing Director | 23-Jan-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Praveen Marimuthu | Director | 23-Jan-2019 | Current |
| Kokila Marimuthu | Director | 23-Jan-2019 | Current |
Financial Performance of Ponni Symbiologicals.
Ponni Symbiologicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 107.39% increase. The company also saw a substantial fall in profitability, with a 158.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 235.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ponni Symbiologicals?
Unlock access to Ponni Symbiologicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Marisym Biologicals Private LimitedActive 5 years 11 monthsPraveen Marimuthu, Preethi Marimuthu and 1 more are mutual person
Tropical Biosciences Private LimitedActive 10 years 6 monthsPreethi Marimuthu and Kokila Marimuthu are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ponni Symbiologicals?
Unlock and access historical data on people associated with Ponni Symbiologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ponni Symbiologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ponni Symbiologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
